-
公开(公告)号：US20060140866A1
公开(公告)日：2006-06-29
申请号：US11361628
申请日：2006-02-24
申请人： Nikolai Zefirov , Andrei Afanasiev , Svetlana Afanasieva , Sergei Bachurin , Sergei Tkachenko , Vladimir Grigoriev , Marina Jurovskaya , Valery Chetverikov , Elizaveta Bukatina , Irina Grigorieva
发明人： Nikolai Zefirov , Andrei Afanasiev , Svetlana Afanasieva , Sergei Bachurin , Sergei Tkachenko , Vladimir Grigoriev , Marina Jurovskaya , Valery Chetverikov , Elizaveta Bukatina , Irina Grigorieva
IPC分类号： A61K49/00
CPC分类号： A61K49/006 , A61K31/437
摘要： Compounds and methods of using these compounds to treat neurodegenerative diseases, especially Alzheimer's disease, are provided. The compounds that are provided for the treatment of neurodegenerative diseases can be represented by a general formula (I): wherein R1 is Me, Et or PhCH2; R2 is H, PhCH2 or 6-Me-3-Py-(CH2)2; and R3 is H, Me or Br. The solid line accompanied by the dotted line i.e. represents a single or double bond and salts thereof with pharmacologically acceptable acids and quaternary derivatives.
摘要翻译： 提供了使用这些化合物治疗神经变性疾病，特别是阿尔茨海默氏病的化合物和方法。 提供用于治疗神经变性疾病的化合物可以由通式（I）表示：其中R 1是Me，Et或PhCH 2; R 2是H，PhCH 2或6-Me-3-Py-（CH 2 2）2。 R 3是H，Me或Br。 虚线中的实线
ie表示单键或双键及其盐与药理学上可接受的酸和季衍生物。
-
公开(公告)号：US09777434B2
公开(公告)日：2017-10-03
申请号：US13334866
申请日：2011-12-22
申请人： Scott Rosencrance , Vladimir Grigoriev , Chen Lu
发明人： Scott Rosencrance , Vladimir Grigoriev , Chen Lu
摘要： Paper strength systems including polyamine-polyamidoamine-epihalohydrin (PPAE) resin are disclosed. Also disclosed are methods of forming a paper including applying a strength system comprising PPAE to cellulosic fiber, as well as the resultant paper.
-
13.发明授权公开(公告)号：US08980056B2
公开(公告)日：2015-03-17
申请号：US12946355
申请日：2010-11-15
申请人： Chen Lu , Vladimir Grigoriev , Scott Rosencrance
发明人： Chen Lu , Vladimir Grigoriev , Scott Rosencrance
CPC分类号： D21H21/18 , D21H17/29 , D21H17/375
摘要： A dry strength additive composition generally includes an anionic and/or amphoteric polyacrylamide having a molecular weight of less than 1,000,000 Daltons, wherein the amphoteric polyacrylamide has a net negative charge; a cationic and/or amphoteric starch; and a cationic non-starch polymer having a charge density greater than 1 milliequivalent per gram (meq/g) at a pH of 3. The components defining the composition can be added to a pulp suspension sequentially or as a pre-blended mixture.
摘要翻译： 干强度添加剂组合物通常包括分子量小于1,000,000道尔顿的阴离子和/或两性聚丙烯酰胺，其中两性聚丙烯酰胺具有净负电荷; 阳离子和/或两性淀粉; 和阳离子非淀粉聚合物，其pH值为3，电荷密度大于1毫当量（meq / g）。限定组合物的组分可以顺序地或作为预混合混合物加入到纸浆悬浮液中。
-
公开(公告)号：US20130160959A1
公开(公告)日：2013-06-27
申请号：US13334866
申请日：2011-12-22
申请人： Scott Rosencrance , Vladimir Grigoriev , Chen Lu
发明人： Scott Rosencrance , Vladimir Grigoriev , Chen Lu
IPC分类号： D21H17/56
摘要： Paper strength systems including polyamine-polyamidoamine-epihalohydrin (PPAE) resin are disclosed. Also disclosed are methods of forming a paper including applying a strength system comprising PPAE to cellulosic fiber, as well as the resultant paper.
摘要翻译： 公开了包括聚胺 - 聚酰胺胺 - 表卤代醇（PPAE））树脂的纸强度体系。 还公开了形成纸的方法，包括将包含PPAE的强度系统应用于纤维素纤维，以及所得纸。
-
15.发明申请公开(公告)号：US20120118523A1
公开(公告)日：2012-05-17
申请号：US12946355
申请日：2010-11-15
申请人： Chen Lu , Vladimir Grigoriev , Scott Rosencrance
发明人： Chen Lu , Vladimir Grigoriev , Scott Rosencrance
CPC分类号： D21H21/18 , D21H17/29 , D21H17/375
摘要： A dry strength additive composition generally includes an anionic and/or amphoteric polyacrylamide having a molecular weight of less than 1,000,000 Daltons, wherein the amphoteric polyacrylamide has a net negative charge; a cationic and/or amphoteric starch; and a cationic non-starch polymer having a charge density greater than 1 milliequivalent per gram (meq/g) at a pH of 3. The components defining the composition can be added to a pulp suspension sequentially or as a pre-blended mixture.
摘要翻译： 干强度添加剂组合物通常包括分子量小于1,000,000道尔顿的阴离子和/或两性聚丙烯酰胺，其中两性聚丙烯酰胺具有净负电荷; 阳离子和/或两性淀粉; 和阳离子非淀粉聚合物，其pH值为3，电荷密度大于1毫当量（meq / g）。限定组合物的组分可以顺序地或作为预混合混合物加入到纸浆悬浮液中。
-
16.发明授权Large mode area fiber for low-loss transmission and amplification of single mode lasers 有权用于单模激光器的低损耗传输和放大的大模式区域光纤公开(公告)号：US07283714B1
公开(公告)日：2007-10-16
申请号：US11611239
申请日：2006-12-15
CPC分类号： G02B6/02009 , G02B6/02361 , G02B6/02366 , G02B6/0365 , G02B6/03666 , G02B6/03688 , H01S3/06729 , H01S3/06741 , H01S3/0675 , H01S3/1618
摘要： A large mode area optical fiber includes a large diameter core (d1 up to 60 μm), and a first cladding (diameter d2) wherein the difference between refractive index (n1) in the core and the first cladding (n2) is very small (Δn 0.4) (n3 is preferably less than 1.3). The small change in refractive index between the core and inner cladding combined with a large change in refractive index between the first cladding and second cladding provides a significantly improved single mode holding waveguide.
摘要翻译： 大模光区域光纤包括大直径芯（d 1至60μm）和第一包层（直径d 2），其中芯和第一包层（n 2）之间的折射率（n 1） 非常小（Deltan <0.002），因此提供非常低的数值孔径核心（NA1在0.02和0.06之间）。 d 2 / d 1 <2的优选比例。 纤维还具有与芯和第一包层相比具有非常低的折射率n 3的第二包层，优选一层空气孔，使得第一包层具有相对较高的数值孔径（NA 2> 0.4）（n 3优选小于1.3）。 芯和内包层之间的折射率的小的变化与第一包层和第二包层之间的折射率的大的变化相结合，提供了显着改进的单模保持波导。
-
公开(公告)号：US20070179174A1
公开(公告)日：2007-08-02
申请号：US11644698
申请日：2006-12-22
IPC分类号： A61K31/4745
CPC分类号： A61K31/4745
摘要： The present invention provides a pharmacological agent based on derivatives of hydrogenated pyrido (4,3-b) indoles and uses thereof. Specifically, the invention provides a geroprotector in the series of hydrogenated pyrido (4,3-b) indoles (several derivatives), which can be used for slowing aging, prolonging lifespan of an individual or cells in an individual, and/or improving quality of life of an individual developing or having a risk of developing age-associated manifestations and/or pathologies.
摘要翻译： 本发明提供了一种基于氢化吡啶并（4,3-b）吲哚衍生物的药理学及其应用。 具体地说，本发明提供了一系列氢化吡啶并（4,3-b）吲哚（几种衍生物）中的保护剂，其可用于减缓老化，延长个体或个体中的细胞的寿命和/或提高质量 的发展中国家或有发展年龄相关表现和/或病态风险的个体的生命。
-
18.发明授权Degrading agent compositions for temporary wet strength systems in tissue products 有权用于组织产品中临时湿强度系统的降解剂组合物公开(公告)号：US08673117B2
公开(公告)日：2014-03-18
申请号：US12894603
申请日：2010-09-30
IPC分类号： D21H17/13 , D21H17/14 , D21H17/28 , D21H17/45 , D21H17/60 , D21H17/64 , D21H17/65 , D21H17/66 , D21H21/20 , D21H23/04 , D21H23/24
CPC分类号： D21H21/20
摘要： A degrading agent composition for use in manufacturing a tissue product generally includes a degrading agent, a degradation inhibiting carrier, and a non-ionic surfactant. The non-ionic surfactant stabilizes the viscosity of the composition as a function of time. The degrading agent composition can be used in combination with a temporary wet strength agent to produce a tissue product exhibiting high initial wet tensile strength and desirable decay properties. Processes for forming the tissue product and pumpable fluids containing the degrading agent composition are also disclosed.
摘要翻译： 用于制造组织产品的降解剂组合物通常包括降解剂，降解抑制载体和非离子表面活性剂。 非离子表面活性剂使组合物的粘度随时间稳定。 降解剂组合物可以与临时湿强力剂组合使用以产生具有高初始湿拉伸强度和所需衰变性能的组织产品。 还公开了用于形成含有降解剂组合物的组织产物和可泵送流体的方法。
-
公开(公告)号：US08582608B2
公开(公告)日：2013-11-12
申请号：US12788764
申请日：2010-05-27
CPC分类号： H01S3/067 , C03C25/12 , H01S3/0619 , H01S3/06737 , H01S3/06745 , H01S3/094019 , H01S3/094042 , H01S3/1616 , H01S3/2316
摘要： A twin fiber laser arrangement is configured with active and passive fibers supporting respective signal and pump lights and a reflective coating surrounding the fibers along a section of the arrangement. The passive fiber has regions covered by respective protective layer and coating-free regions alternating with the layer covered regions, wherein the reflective coating is configured to overlap the protective layer which shields the end of the reflective coating from high power pump light.
摘要翻译： 双纤维激光装置配置有支撑相应信号和泵浦光的有源和无源光纤以及沿着该布置的一部分围绕光纤的反射涂层。 无源光纤具有由相应的保护层和无覆层的区域覆盖的区域，其与覆盖层的区域交替，其中反射涂层被配置为与保护层重叠，该保护层将反射涂层的端部与高功率泵浦光屏蔽。
-
20.发明申请DEGRADING AGENT COMPOSITIONS FOR TEMPORARY WET STRENGTH SYSTEMS IN TISSUE PRODUCTS 有权用于组织产品中临时湿度强度系统的降解剂组合物公开(公告)号：US20120080157A1
公开(公告)日：2012-04-05
申请号：US12894603
申请日：2010-09-30
CPC分类号： D21H21/20
摘要： A degrading agent composition for use in manufacturing a tissue product generally includes a degrading agent, a degradation inhibiting carrier, and a non-ionic surfactant. The non-ionic surfactant stabilizes the viscosity of the composition as a function of time. The degrading agent composition can be used in combination with a temporary wet strength agent to produce a tissue product exhibiting high initial wet tensile strength and desirable decay properties. Processes for forming the tissue product and pumpable fluids containing the degrading agent composition are also disclosed.
摘要翻译： 用于制造组织产品的降解剂组合物通常包括降解剂，降解抑制载体和非离子表面活性剂。 非离子表面活性剂使组合物的粘度随时间稳定。 降解剂组合物可以与临时湿强力剂组合使用以产生具有高初始湿拉伸强度和所需衰变性能的组织产品。 还公开了用于形成含有降解剂组合物的组织产物和可泵送流体的方法。
-
-
-
-
-
-
-
-
-
搜索结果
20 条记录 (耗时 0.022 秒)
